| Brit Therapy Llc | |
|
3002 Se 1st Ave, Ste. 200, Ocala, FL 34471 | |
| (352) 216-6836 | |
| (352) 248-0924 |
| Full Name | Brit Therapy Llc |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist - Hand |
| Location | 3002 Se 1st Ave, Ocala, Florida |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093256984 | NPI | - | NPPES |
| TQFOO | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT9864 (Florida) | Secondary |
| 225XH1200X | Occupational Therapist - Hand | OT4461 (Florida) | Primary |
| Provider Name | Christine D Lopez |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1295733806 PECOS PAC ID: 7315136850 Enrollment ID: I20110113000938 |
News Archive
Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition.
Niusule Biotech Corp. ("Niusule" or the "Company") (OTC Bulletin Board: NIUS), a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced that the Company's popular Gummy Bear products will be distributed in Shanghai, the largest city in China.
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
Today Phadia announced that it has received FDA 510(k) clearance for two new, CLIA Moderate Complexity, EliA autoimmune antibody assays. The new assays will provide physicians with additional tools needed to aid in the diagnosis of Celiac disease. The newly available assays, EliA GliadinDP IgA and EliA GliadinDP IgG (deamidated peptides), have proven to be essential, sensitive and specific markers to aid in the diagnosis of celiac disease.
› Verified 6 days ago
| Provider Name | Anne Sarah Forrest |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1306201025 PECOS PAC ID: 6608154307 Enrollment ID: I20161101001108 |
News Archive
Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition.
Niusule Biotech Corp. ("Niusule" or the "Company") (OTC Bulletin Board: NIUS), a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced that the Company's popular Gummy Bear products will be distributed in Shanghai, the largest city in China.
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
Today Phadia announced that it has received FDA 510(k) clearance for two new, CLIA Moderate Complexity, EliA autoimmune antibody assays. The new assays will provide physicians with additional tools needed to aid in the diagnosis of Celiac disease. The newly available assays, EliA GliadinDP IgA and EliA GliadinDP IgG (deamidated peptides), have proven to be essential, sensitive and specific markers to aid in the diagnosis of celiac disease.
› Verified 6 days ago
| Provider Name | Arneli Alba Perez |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1477021939 PECOS PAC ID: 4183961923 Enrollment ID: I20190131002867 |
News Archive
Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition.
Niusule Biotech Corp. ("Niusule" or the "Company") (OTC Bulletin Board: NIUS), a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced that the Company's popular Gummy Bear products will be distributed in Shanghai, the largest city in China.
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
Today Phadia announced that it has received FDA 510(k) clearance for two new, CLIA Moderate Complexity, EliA autoimmune antibody assays. The new assays will provide physicians with additional tools needed to aid in the diagnosis of Celiac disease. The newly available assays, EliA GliadinDP IgA and EliA GliadinDP IgG (deamidated peptides), have proven to be essential, sensitive and specific markers to aid in the diagnosis of celiac disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brit Therapy Llc 3002 Se 1st Ave, Ste. 200, Ocala, FL 34471-0477 Ph: (352) 216-6836 | Brit Therapy Llc 3002 Se 1st Ave, Ste. 200, Ocala, FL 34471 Ph: (352) 216-6836 |
News Archive
Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition.
Niusule Biotech Corp. ("Niusule" or the "Company") (OTC Bulletin Board: NIUS), a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced that the Company's popular Gummy Bear products will be distributed in Shanghai, the largest city in China.
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
Today Phadia announced that it has received FDA 510(k) clearance for two new, CLIA Moderate Complexity, EliA autoimmune antibody assays. The new assays will provide physicians with additional tools needed to aid in the diagnosis of Celiac disease. The newly available assays, EliA GliadinDP IgA and EliA GliadinDP IgG (deamidated peptides), have proven to be essential, sensitive and specific markers to aid in the diagnosis of celiac disease.
› Verified 6 days ago
Ivelisse M Cruz-lopez, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1501 Se 24th Rd, Ocala, FL 34471 Phone: 352-629-8900 | |
Kaitlyn M Littlejohn-oram, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2300 Se 17th St Ste 500, Ocala, FL 34471 Phone: 352-867-0444 | |
Sarah Leppert, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2620 Se Maricamp Rd, Ocala, FL 34471 Phone: 352-732-8883 Fax: 352-351-4219 | |
James M Sparkman, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4511 Sw 48th Ave, Ocala, FL 34474 Phone: 866-236-1808 Fax: 866-236-1808 | |
Talalai's Occupational Therapy Services, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3929 Sw 106th Pl, Ocala, FL 34476 Phone: 732-742-9840 | |
Anya Klumpp, OTD/OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3019 Sw 27th Ave Ste 202, Ocala, FL 34471 Phone: 352-275-5778 | |
Lisa Marlene Thompson-goertz, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 9280 Sw 81st Ct, Ocala, FL 34481 Phone: 352-509-5201 |